Department of Psychiatry, University of California San Diego, La Jolla, CA, 92093, USA.
Center for Behavior Genetics of Aging, University of California San Diego, La Jolla, CA, 92093, USA.
Alzheimers Res Ther. 2022 Dec 16;14(1):189. doi: 10.1186/s13195-022-01134-0.
Blood-based neurofilament light chain (NfL) is a promising biomarker of neurodegeneration across multiple neurodegenerative diseases. However, blood-based NfL is highly associated with renal function in older adults, which leads to the concern that blood-based NfL levels may be influenced by renal function, rather than neurodegeneration alone. Despite growing interest in using blood-based NfL as a biomarker of neurodegeneration in research and clinical practices, whether renal function should always be accounted for in these settings remains unclear. Moreover, the mechanisms underlying this association between blood-based measures of NfL and renal function remain elusive. In this study, we first evaluated the effect of renal function on the associations of plasma NfL with other measures of neurodegeneration. We then examined the extent of genetic and environmental contributions to the association between plasma NfL and renal function.
In a sample of 393 adults (mean age=75.22 years, range=54-90), we examined the associations of plasma NfL with cerebrospinal fluid (CSF) NfL and brain volumetric measures before and after adjusting for levels of serum creatinine (an index of renal function). In an independent sample of 969 men (mean age=67.57 years, range=61-73) that include monozygotic and dizygotic twin pairs, we replicated the same analyses and leveraged biometrical twin modeling to examine the genetic and environmental influences on the plasma NfL and creatinine association.
Plasma NfL's associations with cerebrospinal fluid NfL and brain volumetric measures did not meaningfully change after adjusting for creatinine levels. Both plasma NfL and creatinine were significantly heritable (h=0.54 and 0.60, respectively). Their phenotypic correlation (r=0.38) was moderately explained by shared genetic influences (genetic correlation=0.46) and unique environmental influences (unique environmental correlation=0.27).
Adjusting for renal function is unnecessary when assessing associations between plasma NfL and other measures of neurodegeneration but is necessary if plasma NfL is compared to a cutoff for classifying neurodegeneration-positive versus neurodegeneration-negative individuals. Blood-based measures of NfL and renal function are heritable and share common genetic influences.
血液神经丝轻链(NfL)是多种神经退行性疾病中神经退行性变的有前途的生物标志物。然而,在老年人中,血液 NfL 与肾功能高度相关,这导致人们担心血液 NfL 水平可能受到肾功能的影响,而不仅仅是神经退行性变本身。尽管研究和临床实践中越来越多地将血液 NfL 用作神经退行性变的生物标志物,但在这些情况下是否始终需要考虑肾功能仍不清楚。此外,血液 NfL 与肾功能之间这种关联的机制仍不清楚。在这项研究中,我们首先评估了肾功能对血浆 NfL 与其他神经退行性变测量值之间关联的影响。然后,我们检查了血浆 NfL 与肾功能之间关联的遗传和环境贡献程度。
在 393 名成年人(平均年龄=75.22 岁,范围=54-90)的样本中,我们在调整血清肌酐水平(肾功能指标)之前和之后,检查了血浆 NfL 与脑脊液(CSF)NfL 和脑容积测量值之间的关联。在包含同卵双胞胎和异卵双胞胎的 969 名男性(平均年龄=67.57 岁,范围=61-73)的独立样本中,我们复制了相同的分析,并利用生物测量双胞胎模型来检查血浆 NfL 和肌酐关联的遗传和环境影响。
在调整肌酐水平后,血浆 NfL 与 CSF NfL 和脑容积测量值的关联没有明显变化。血浆 NfL 和肌酐都具有显著的遗传性(h=0.54 和 0.60)。它们的表型相关性(r=0.38)由共享遗传影响(遗传相关性=0.46)和独特环境影响(独特环境相关性=0.27)中度解释。
在评估血浆 NfL 与其他神经退行性变测量值之间的关联时,调整肾功能是不必要的,但如果将血浆 NfL 与用于分类神经退行性变阳性与阴性个体的截止值进行比较,则调整肾功能是必要的。血液 NfL 和肾功能是可遗传的,并且具有共同的遗传影响。